NCT04669587
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04669587
Title ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) (ENZENO)
Acronym ENZENO
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EnhancedBio USA Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Swedish Cancer Institute RECRUITING Seattle Washington 98104 United States Details
National Cancer Center RECRUITING Goyang-si Gyeonggi-do 10408 South Korea Details
CHA Bundang Medical Center, CHA University RECRUITING Seongnam-si 13496 South Korea Details
Korea University Anam Hospital RECRUITING Seoul 02841 South Korea Details
Kangbuk Samsung Hospital RECRUITING Seoul 03181 South Korea Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul 03722 South Korea Details
Asan Medical Center RECRUITING Seoul 05505 South Korea Details
The Catholic University of Korea, Seoul St. Mary's Hospital RECRUITING Seoul 06591 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field